What is she best known for?
The fields of study she is best known for:
- Gene
- Cancer
- Internal medicine
Mignon L. Loh mainly focuses on Cancer research, Leukemia, Immunology, Internal medicine and Mutation.
Her research in Cancer research intersects with topics in Tyrosine kinase, STAT5, Philadelphia chromosome, Neuroblastoma RAS viral oncogene homolog and Juvenile myelomonocytic leukemia.
Her Leukemia research includes themes of Missense mutation, Chronic myelomonocytic leukemia, Transplantation and Candidate gene.
Her Internal medicine study integrates concerns from other disciplines, such as Oncology and Genotype.
Her Mutation study combines topics in areas such as Molecular biology and Janus kinase.
Her Myeloid leukemia study incorporates themes from DNA microarray, Microarray databases, Significance analysis of microarrays and Bioinformatics.
Her most cited work include:
- Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. (11046 citations)
- The genetic basis of early T-cell precursor acute lymphoblastic leukaemia (1109 citations)
- Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia (924 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of study are Internal medicine, Oncology, Cancer research, Leukemia and Immunology.
Her Minimal residual disease, Acute lymphocytic leukemia, Chemotherapy and Lymphoblastic Leukemia study in the realm of Internal medicine interacts with subjects such as Cog.
Her Acute lymphocytic leukemia research focuses on Vincristine and how it connects with Gastroenterology.
Her studies deal with areas such as Cancer, Hematopoietic stem cell transplantation, Clinical trial, Methotrexate and Young adult as well as Oncology.
Her studies deal with areas such as Mutation, Juvenile myelomonocytic leukemia, Neuroblastoma RAS viral oncogene homolog and PTPN11 as well as Cancer research.
Mignon L. Loh interconnects Molecular biology, Myeloid leukemia and Bone marrow in the investigation of issues within Leukemia.
She most often published in these fields:
- Internal medicine (42.71%)
- Oncology (32.85%)
- Cancer research (33.26%)
What were the highlights of her more recent work (between 2018-2021)?
- Internal medicine (42.71%)
- Oncology (32.85%)
- Leukemia (31.42%)
In recent papers she was focusing on the following fields of study:
Her main research concerns Internal medicine, Oncology, Leukemia, Lymphoblastic Leukemia and Cancer research.
Her work on Hematopoietic stem cell transplantation, Young adult, Minimal residual disease and B lymphoblastic leukemia as part of general Internal medicine study is frequently connected to Cog, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
Her Oncology research is multidisciplinary, incorporating elements of Clinical trial, Refractory, Standard Risk, Chemotherapy and Cohort.
Her Leukemia study incorporates themes from Cancer, Haematopoiesis and Myeloid leukemia.
Her Myeloid leukemia study which covers Childhood leukemia that intersects with Germline.
Mignon L. Loh does research in Cancer research, focusing on Myeloid specifically.
Between 2018 and 2021, her most popular works were:
- PAX5 -driven subtypes of B-progenitor acute lymphoblastic leukemia (105 citations)
- Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia (75 citations)
- A Randomized Phase 3 Trial of Blinatumomab Vs. Chemotherapy As Post-Reinduction Therapy in High and Intermediate Risk (HR/IR) First Relapse of B-Acute Lymphoblastic Leukemia (B-ALL) in Children and Adolescents/Young Adults (AYAs) Demonstrates Superior Efficacy and Tolerability of Blinatumomab: A Report from Children's Oncology Group Study AALL1331 (35 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Mignon L. Loh mainly investigates Internal medicine, Oncology, Cancer research, Lymphoblastic Leukemia and Genetics.
Her Oncology research includes elements of Young adult, Clinical trial, Refractory and Chemotherapy.
Her Cancer research research is multidisciplinary, relying on both RNA, Cell, Leukemia and In vivo.
Her Leukemia course of study focuses on Haematopoiesis and Tumor initiation, Progenitor cell and Lymphoblast.
Her Asparaginase study in the realm of Lymphoblastic Leukemia connects with subjects such as Extramural.
Her Cohort study deals with Acute leukemia intersecting with Myeloid leukemia.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
